These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18743825)

  • 21. Observations on 360 cases of primary syphilis (treated with penicillin alone or with penicillin plus mapharsen and bismuth).
    JONES EH
    Ohio State Med J; 1951 Feb; 47(2):131-3. PubMed ID: 14807370
    [No Abstract]   [Full Text] [Related]  

  • 22. The intensive treatment of early syphilis: in 9 to 15 weeks with triweekly injections of mapharsen (oxophenarsine hydrochloride) and concomitant weekly injections of bismuth: an analysis of the results in 110 cases.
    DEXTER DD
    Am J Syph Gonorrhea Vener Dis; 1947 Sep; 31(5):533-41. PubMed ID: 20262385
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemorrhagic ancephalopathy following five day treatment of early syphilis with massive doses of mapharsen; report of a case with recovery.
    HEILBRUNN G; HOFFENBERG N
    Ill Med J; 1945 Nov; 88():258-63. PubMed ID: 21007246
    [No Abstract]   [Full Text] [Related]  

  • 24. A long-term evaluation of the efficacy of mapharsen and typhoid vaccine, including a comparison with penicillin, in the treatment of early syphilis.
    THOMAS EW; GLEESEN GA
    Am J Syph Gonorrhea Vener Dis; 1953 Sep; 37(5):458-65. PubMed ID: 13080556
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy of early syphilis with artificial fever in combination with mapharsen, bismuth, and penicillin.
    O'BRIEN JF; RODRIQUEZ J; SMITH CA; SCHWEMLEIN GX
    Am J Syph Gonorrhea Vener Dis; 1952 Sep; 36(5):451-6. PubMed ID: 14952686
    [No Abstract]   [Full Text] [Related]  

  • 26. [The action of mapharsen on serum reactions to the lue].
    MARCHI C
    Rass Med Sarda; 1948; 50 Suppl.(3-4):27-33. PubMed ID: 18105196
    [No Abstract]   [Full Text] [Related]  

  • 27. Reactions to twenty-day intensive therapy with mapharsen and bismuth for syphilis with a note on the use of BAL in their management.
    CORMIA FE; BLAUNER SG
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):135-49. PubMed ID: 20289293
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of acute syphilitic orchitis and generalized syphilis of rabbits with repository penicillin products alone and in combination with mapharsen and bismuth salicylate.
    KOLMER JA
    Am J Syph Gonorrhea Vener Dis; 1950 Jan; 34(1):45-56. PubMed ID: 15398704
    [No Abstract]   [Full Text] [Related]  

  • 29. [The neo-arsenic antisyphilitic mapharsen and standard methods of use].
    SASA K
    Nihon Ishikai Zasshi; 1948 Jun; 22(5):166-8. PubMed ID: 18884917
    [No Abstract]   [Full Text] [Related]  

  • 30. Penicillin in the treatment of experimental syphilis of rabbits. VII. Penicillin "S-R" and procaine penicillin G in peanut oil with aluminum monostearate, alone and in combination with oxophenarsine hydrochloride (mapharsen) or bismuth subsalicylate.
    KOLMER JA
    AMA Arch Derm Syphilol; 1951 Aug; 64(2):169-76. PubMed ID: 14856407
    [No Abstract]   [Full Text] [Related]  

  • 31. THE VALUE OF MAPHARSEN IN THE TREATMENT OF CONGENITAL SYPHILIS.
    Morgan EA
    Can Med Assoc J; 1938 Jan; 38(1):53-5. PubMed ID: 20320834
    [No Abstract]   [Full Text] [Related]  

  • 32. The Use of Mapharsen in the Treatment of Syphilis.
    Peterson SC
    Can Med Assoc J; 1937 Feb; 36(2):172-3. PubMed ID: 20320530
    [No Abstract]   [Full Text] [Related]  

  • 33. Mapharsen in Treatment of Syphilis.
    Br Med J; 1936 Feb; 1(3918):269-70. PubMed ID: 20779722
    [No Abstract]   [Full Text] [Related]  

  • 34. Arthur Tatum, Parke-Davis, and the discovery of Mapharsen as an antisyphilitic agent.
    Swann JP
    J Hist Med Allied Sci; 1985 Apr; 40(2):167-87. PubMed ID: 3891839
    [No Abstract]   [Full Text] [Related]  

  • 35. Reiter's syndrome; a report of two cases with response in one to large doses of mapharsen.
    KHOURY EN
    J Urol; 1947 Oct; 58(4):269-71. PubMed ID: 20266241
    [No Abstract]   [Full Text] [Related]  

  • 36. [Jaundice resulting from mapharsen-bismuth and mapharsen-mercury treatment].
    SHAPOSHNIKOV OK
    Vestn Venerol Dermatol; 1948; 29(1):55. PubMed ID: 18887751
    [No Abstract]   [Full Text] [Related]  

  • 37. BAL (2, 3-DIMERCAPTOPROPANOL) IN THE TREATMENT OF MASSIVE OVERDOSAGE WITH MAPHARSEN.
    Armstrong CD; Fleming WJ; Thalmann WG
    Calif Med; 1948 Oct; 69(4):247-52. PubMed ID: 18731546
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new type of cure by the mapharsen].
    CHIAPPONI ; DAEN
    Bull Mens Soc Med Mil Fr; 1945; 39(10):309-14. PubMed ID: 21014987
    [No Abstract]   [Full Text] [Related]  

  • 39. THE INFLUENCE OF METHYL CHALCONE OF HESPERIDIN ON THE TOXICITY OF MAPHARSEN IN RABBITS.
    Goldstein DH; Stolman A; Goldfarb AE
    Science; 1943 Sep; 98(2541):245-6. PubMed ID: 17752700
    [No Abstract]   [Full Text] [Related]  

  • 40. Mapharsen as an Antisyphilitic Arsenical.
    Levin EA
    Cal West Med; 1940 Nov; 53(5):207. PubMed ID: 18745754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.